Restoration of the gut microbial habitat as a disease therapy

被引:8
|
作者
Relman, David A. [1 ,2 ,3 ]
机构
[1] Stanford Univ, Dept Med, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA
[3] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA
关键词
INFECTION; MICE;
D O I
10.1038/nbt.2475
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
[No abstract available]
引用
收藏
页码:35 / 37
页数:4
相关论文
共 50 条
  • [1] Restoration of the gut microbial habitat as a disease therapy
    David A Relman
    Nature Biotechnology, 2013, 31 : 35 - 37
  • [2] Gut microbial metabolites in cancer therapy
    Song, Panwei
    Peng, Zhi
    Guo, Xiaohuan
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2025, 36 (01): : 55 - 69
  • [3] Gut Microbial Changes in Inflammatory Bowel Disease Patients in Response to Biologic Therapy
    Yilmaz, Bahtiyar
    Juillerat, Pascal
    Bravo, Francisco D.
    Wiest, Reiner
    Macpherson, Andrew
    SWISS MEDICAL WEEKLY, 2017, 147 : 12S - 12S
  • [4] Gut microbial metabolites in health and disease
    Flint, Harry J.
    GUT MICROBES, 2016, 7 (03) : 187 - 188
  • [5] As the worm turns: The earthworm gut as a transient habitat for soil microbial biomes
    Drake, Harold L.
    Horn, Marcus A.
    ANNUAL REVIEW OF MICROBIOLOGY, 2007, 61 : 169 - 189
  • [6] The gut microbial influence on cholestatic liver disease
    Kummen, Martin
    Hov, Johannes R.
    LIVER INTERNATIONAL, 2019, 39 (07) : 1186 - 1196
  • [7] The microbial organ in the gut as a driver of homeostasis and disease
    Lyte, Mark
    MEDICAL HYPOTHESES, 2010, 74 (04) : 634 - 638
  • [8] Microbial Therapy in Liver Disease: Probiotics Probe the Microbiome-Gut-Liver-Brain Axis
    Victor, David W.
    Quigley, Eamonn M. M.
    GASTROENTEROLOGY, 2014, 147 (06) : 1216 - 1218
  • [9] Reduction in Lyme Disease Risk as an Economic Benefit of Habitat Restoration
    Morlando, Scott
    Schmidt, Stephen J.
    LoGiudice, Kathleen
    RESTORATION ECOLOGY, 2012, 20 (04) : 498 - 504
  • [10] Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19
    Daizee Talukdar
    Purbita Bandopadhyay
    Yogiraj Ray
    Shekhar Ranjan Paul
    Jafar Sarif
    Ranit D’Rozario
    Abhishake Lahiri
    Santanu Das
    Debaleena Bhowmick
    Shilpak Chatterjee
    Bhabatosh Das
    Dipyaman Ganguly
    Gut Pathogens, 15